Angioplasty

Periprocedural Infarction vs. Spontaneous Infarction: Prognostic Significance 

Original title:&nbsp;Comparison of the Prognosis of Spontaneous and Percutaneous Coronary Intervention&ndash;Related Myocardial Infarction.&nbsp;Reference:&nbsp;Sergio Leonardi, MD et al. Journal of the American College of Cardiology Vol. 60, No. 22, 2012 Clinical significance of myocardial infarction (MI) associated to coronary angioplasty is a controversial issue worldwide. Most of research on coronary disease includes it as a primary<a href="https://solaci.org/en/2012/12/03/periprocedural-infarction-vs-spontaneous-infarction-prognostic-significance/" title="Read more" >...</a>

High-dose atorvastatin for prevention of contrast nephropathy

Original title:&nbsp;Impact of a High Loading Dose of Atorvastatin on Contrast-Induced Acute Kidney Injury.&nbsp;Reference:&nbsp;Quintavalle et al. CIRCULATIONAHA.112.10331, 2012 Patients included in this study represent a subgroup with chronic renal failure (CRF) enrolled in the NAPLES II trial who were randomized to atorvastatin 80 mg 24 hours before angioplasty, (n = 202) versus the control group<a href="https://solaci.org/en/2012/11/27/high-dose-atorvastatin-for-prevention-of-contrast-nephropathy/" title="Read more" >...</a>

Risk score of thrombosis in patients with acute coronary syndrome

Original title:&nbsp;Development and Validation of a Stent Thrombosis Risk Score in Patients With Acute Coronary Syndromes.&nbsp;Reference:&nbsp;George D. Dangas et al. J Am Coll Cardiol Intv 2012;5:1097&ndash;105. The implantation of a stent in a pro thrombotic condition such as acute coronary syndrome (ACS) is associated with a higher incidence of stent thrombosis.&nbsp; There is no data<a href="https://solaci.org/en/2012/11/23/risk-score-of-thrombosis-in-patients-with-acute-coronary-syndrome/" title="Read more" >...</a>

Clinical Significance of Collaterals in Chronic Total Occlusions

Again in the bifurcation, less is more.

It has been reported that the two stents technique is not superior to a provisional stent when treating bifurcations. However, the optimal approach to rescue a secondary branch (SB) when initially opting for provisional stenting has not been established.  &nbsp; The aim of this study was to determine angioplasty indication using balloon or stent for<a href="https://solaci.org/en/2012/11/20/again-in-the-bifurcation-less-is-more/" title="Read more" >...</a>

The use of a paclitaxel eluting balloon in small vessels

Original title:&nbsp;A Randomized Multicenter Study Comparing a Paclitaxel Drug-Eluting Balloon With a Paclitaxel-Eluting Stent in Small Coronary Vessels. The BELLO (Balloon Elution and Late Loss Optimization) Study&nbsp;Reference:&nbsp;Referencia: Azeem Latib et al J Am Coll Cardiol 2012;()doi:10.1016/j.jacc.2012.09.020 The utility of paclitaxel-eluting balloons to treat in-stent restenosis is known but data for novo lesions is more limited.&nbsp;<a href="https://solaci.org/en/2012/11/16/the-use-of-a-paclitaxel-eluting-balloon-in-small-vessels/" title="Read more" >...</a>

A new paradigm in the treatment of in-stent restenosis?

Original title:&nbsp;ISAR DESIRE 3: Drug-eluting balloon is best option for restenosis of limus-eluting stents&nbsp;Reference:&nbsp;Dr Robert Byrne. TCT 2012. Miami, Fl. The first of the ISAR DESIRE trials showed that drug-eluting stents (DES) were the best strategy for treating restenosis of a bare metal stent, the second ISAR DESIRE trial tested the hypothesis of changing or<a href="https://solaci.org/en/2012/11/11/a-new-paradigm-in-the-treatment-of-in-stent-restenosis/" title="Read more" >...</a>

Drug eluting balloon; a valid alternative to treat in-stent restenosis in the superficial femoral artery

Original title:&nbsp;Drug-Eluting Balloon for Treatment of Superficial Femoral Artery In-Stent Restenosis&nbsp;Reference:&nbsp;Eugenio Stabile et al. Journal of the American College of Cardiology 60:1739&ndash;42 (2012) Drug eluting balloon; a valid alternative to treat in-stent restenosis in the superficial femoral artery&nbsp; This prospective registry included 39 patients who received Paclitaxel-Eluting Balloon Angioplasty, (IN.PACT, Medtronic, Minneapolis, Minnesota), for in-stent<a href="https://solaci.org/en/2012/11/09/drug-eluting-balloon-a-valid-alternative-to-treat-in-stent-restenosis-in-the-superficial-femoral-artery/" title="Read more" >...</a>

Diabetics with multivessel, must keep waiting.

Original title:&nbsp;Strategies for Multivessel Revascularization in Patients with Diabetes. The FREEDOM Trial.&nbsp;Reference:&nbsp;Michael E. Farkouh et al. N Engl J Med 2012. DOI: 10.1056/NEJMoa1211585 This study was designed to determine the best revascularization strategy in diabetic patients with multivessel using current techniques of angioplasty (PCI) and surgery (CABG). Randomized 1:1 diabetic patients with injuries &gt; 70%<a href="https://solaci.org/en/2012/11/08/diabetics-with-multivessel-must-keep-waiting/" title="Read more" >...</a>

Predictors of invasive versus conservative treatment in elderly patients with acute coronary syndromes.

Original title:&nbsp;Predictors of Treatment in Acute Coronary Syndromes in the Elderly: Impact on Decision Making and Clinical Outcome After Interventional Versus Conservative Treatment.&nbsp;Reference:&nbsp;Harald Rittger et al. Catheterization and Cardiovascular Interventions 80:735&ndash;743 (2012). This study, recently published in Cath Cardiovasc Interven, was performed to determine the factors that helped physicians decide to be conservative or invasive.<a href="https://solaci.org/en/2012/11/01/predictors-of-invasive-versus-conservative-treatment-in-elderly-patients-with-acute-coronary-syndromes/" title="Read more" >...</a>

Global Risk Score for stratification of patients with multivessel coronary artery disease: A wider look

Reference: Serruys et al J Am Coll Cardiol Intv 2012;5:606&ndash;17 SYNTAX Analysis study demonstrates the utility of a new risk score for patients stratification with left main coronary artery or multivessel disease. Numerous studies have demonstrated the value of SYNTAX score to stratify risk of angioplasty and decision-making (angioplasty versus surgery) in patients with multivessel<a href="https://solaci.org/en/2012/10/01/global-risk-score-for-stratification-of-patients-with-multivessel-coronary-artery-disease-a-wider-look/" title="Read more" >...</a>

Top